Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Medeva acquires rights to nicotine for ulcerative colitis

Oct. 11, 1996

European approvals for Zantac

Oct. 11, 1996

Zenyaku Kogyo discloses anti-Helicobacter pylori agents

Oct. 11, 1996

Gene for hereditary pancreatitis identified

Oct. 4, 1996

Hepatitis A vaccine approved in Canada

Oct. 4, 1996

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

LeukoSite and Oxford Asymmetry collaboration in IBD

Oct. 4, 1996

Promising phase III results with treatment for ulcerative colitis

Oct. 4, 1996

Clinical trial on oral H. pylori vaccine completed

Oct. 4, 1996

GI drugs under development at Takeda

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...